Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Vegetarians should take B vitamin supplements to avoid health issues.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Plant compounds may help manage PCOS, endometriosis, and menstrual issues.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Women with PCOS have higher levels of thyroid autoantibodies.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Lower ghrelin levels and certain gene variations may increase acne risk.

Higher cholesterol levels increase aggressive prostate cancer risk.

Lower SHBG levels may increase the risk of PCOS.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.